NAMI Pharma Marketing Blog Grassley
View PDF of blog article here
View PDF of blog article here
Fortune Magazine confirms our report (October) that "The prospect of a bird flu outbreak may be panicking people around the globe, but it’s proving to be very good news for Defense Secretary."
The primary promoters–inventors, one might say– of diagnosing children with "bipolar" disorder, who for over a decade, aggressively promoted the biopolar diagnosis and use of antipsychotics in children, were disciplined by Harvard University and its affiliated Massachusetts General Hospital.
The BMJ news report (below) is included in the Congressional Record transcript of the Congressional hearing at which FDA officials were grilled about why they prevented Dr. Andrew Mosholder from delivering his analysis report of the pediatric antidepressant clinical trials. http://a257.g.akamaitech.net/7/257/2422/12jan20051100/www.access.gpo.gov/congress/house/pdf/108hrg/96099.pdf
ACRE’s mission is to persuade physicians that MORE rather than less industry involvement in Continuing Medical Education programs is good for patients–much as industry’s "Harry and Louise" ads were aimed at convincing the public that universal healthcare was BAD for them.
Two high ranking FDA officials’ conflicts of interest have led one to resign, the other is under investigation by the Inspector General of the Department of Health and Human Services:
An audit by Daniel Levinson, Inspector General of DHHS, confirms what has already been documented: that antipsychotics are widely misprescribed for unapproved uses and taxpayers are saddled with the high cost through Medicaid and Medicare.